Chronic Myelogenous Leukemia in a 66-Year-Old Male with Concurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

被引:0
作者
Szymanski, Linda J. [1 ]
Ayyad, Hashem [1 ]
Inamdar, Kedar [1 ]
机构
[1] Henry Ford Hosp, Dept Pathol, Detroit, MI 48202 USA
来源
LABMEDICINE | 2013年 / 44卷 / 02期
关键词
flow cytometry; hematology; hematopathology; molecular diagnostics; CHRONIC MYELOID-LEUKEMIA; DASATINIB; PATIENT;
D O I
10.1309/LM5JS4LSSLX7UQYV
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Patient: A 66-year-old Caucasian male. Chief Complaint: The patient felt tired and was eating less than usual. Previously, the patient could ride his bike for 3 miles, but now can barely complete 1 mile. Medical History: Significant for persistent lymphocytosis for the past 10 years and recently diagnosed with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) by flow cytometry on peripheral blood. He also has a history of hyperlipidemia, diabetes mellitus, and obstructive sleep apnea. Social History: The patient does not smoke or use illicit drugs. He uses alcohol occasionally. The patient is married and is retired from an automobile supply company. Family History: Noncontributory. None of his family members have a history of blood disorders. Physical Examination: Significant for the following: alert; oriented to time, place, and person; neck: no palpable lymphadenopathy; heart and lung: unremarkable; abdomen: obese and soft, no palpable hepatosplenomegaly. Vital signs: Blood pressure: 137/58 mmHg; pulse: 68/minute; respiratory rate: 12/minute; temperature: 37 C. Principal Laboratory Findings: Laboratory test results are in Table 1. Additional Testing: The molecular diagnostic test Janus kinase 2 (JAK2) V617F mutation was ordered. A peripheral blood smear at the hematologist's office was abnormal 3 months later. Subsequently, on the peripheral blood specimen the molecular test assessing presence of BCR/ABL1 mRNA transcript producing the 210-kDa protein (p210) was ordered and a bone marrow biopsy with aspirate was performed. The bone marrow aspirate was also submitted for morphologic, cytogenetic, and flow cytometric evaluations (Images 1 and 2).
引用
收藏
页码:142 / 146
页数:5
相关论文
共 12 条
[1]  
[Anonymous], SEER CANC STAT REV 1
[2]  
Bartik MM, 1998, SEMIN ONCOL, V25, P27
[3]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[4]  
Bhagavathi S, 2008, ANN CLIN LAB SCI, V38, P405
[5]  
Bhatia R, 2008, HEMATOLOGY BASIC PRI, P1109
[6]   Philadelphia-positive leukemia: a personal perspective [J].
Heisterkamp, N ;
Groffen, J .
ONCOGENE, 2002, 21 (56) :8536-8540
[7]   Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765 [J].
Herman, Sarah E. M. ;
Gordon, Amber L. ;
Hertlein, Erin ;
Ramanunni, Asha ;
Zhang, Xiaoli ;
Jaglowski, Samantha ;
Flynn, Joseph ;
Jones, Jeffrey ;
Blum, Kristie A. ;
Buggy, Joseph J. ;
Hamdy, Ahmed ;
Johnson, Amy J. ;
Byrd, John C. .
BLOOD, 2011, 117 (23) :6287-6296
[8]   Solid tumors after chronic lymphocytic leukemia [J].
Hisada, M ;
Biggar, RJ ;
Greene, MH ;
Fraument, JF ;
Travis, LB .
BLOOD, 2001, 98 (06) :1979-1981
[9]   The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo [J].
Ponader, Sabine ;
Chen, Shih-Shih ;
Buggy, Joseph J. ;
Balakrishnan, Kumudha ;
Gandhi, Varsha ;
Wierda, William G. ;
Keating, Michael J. ;
O'Brien, Susan ;
Chiorazzi, Nicholas ;
Burger, Jan A. .
BLOOD, 2012, 119 (05) :1182-1189
[10]   Response to Dasatinib in a Patient with Concomitant Chronic Myeloid Leukemia and Chronic Lymphocytic Leukemia [J].
Serpa, Mariana ;
Bendit, Israel ;
Seguro, Fernanda ;
Xavier, Flavia ;
Cavalcante, Marcela ;
Steinbaum, Daniel ;
Nardinelli, Luciana ;
Aldred, Vera Lucia ;
de Paula, Henrique Moura ;
Dorlhiac-Llacer, Pedro Enrique .
ACTA HAEMATOLOGICA, 2010, 124 (02) :105-109